JP2014080432A5 - - Google Patents

Download PDF

Info

Publication number
JP2014080432A5
JP2014080432A5 JP2014013224A JP2014013224A JP2014080432A5 JP 2014080432 A5 JP2014080432 A5 JP 2014080432A5 JP 2014013224 A JP2014013224 A JP 2014013224A JP 2014013224 A JP2014013224 A JP 2014013224A JP 2014080432 A5 JP2014080432 A5 JP 2014080432A5
Authority
JP
Japan
Prior art keywords
fatty acid
pharmaceutically acceptable
acceptable salt
unsaturated fatty
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014013224A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014080432A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014013224A priority Critical patent/JP2014080432A/ja
Priority claimed from JP2014013224A external-priority patent/JP2014080432A/ja
Publication of JP2014080432A publication Critical patent/JP2014080432A/ja
Publication of JP2014080432A5 publication Critical patent/JP2014080432A5/ja
Pending legal-status Critical Current

Links

JP2014013224A 2008-06-11 2014-01-28 ヒトアドレナリンβ３受容体リガンド、これを含む食品及び医薬品 Pending JP2014080432A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014013224A JP2014080432A (ja) 2008-06-11 2014-01-28 ヒトアドレナリンβ３受容体リガンド、これを含む食品及び医薬品

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008153390 2008-06-11
JP2008153390 2008-06-11
JP2014013224A JP2014080432A (ja) 2008-06-11 2014-01-28 ヒトアドレナリンβ３受容体リガンド、これを含む食品及び医薬品

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010516877A Division JP5544660B2 (ja) 2008-06-11 2009-06-11 ヒトアドレナリンβ３受容体リガンド、これを含む食品及び医薬品

Publications (2)

Publication Number Publication Date
JP2014080432A JP2014080432A (ja) 2014-05-08
JP2014080432A5 true JP2014080432A5 (enExample) 2014-06-19

Family

ID=41416798

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010516877A Active JP5544660B2 (ja) 2008-06-11 2009-06-11 ヒトアドレナリンβ３受容体リガンド、これを含む食品及び医薬品
JP2014013224A Pending JP2014080432A (ja) 2008-06-11 2014-01-28 ヒトアドレナリンβ３受容体リガンド、これを含む食品及び医薬品

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010516877A Active JP5544660B2 (ja) 2008-06-11 2009-06-11 ヒトアドレナリンβ３受容体リガンド、これを含む食品及び医薬品

Country Status (7)

Country Link
US (1) US20110098358A1 (enExample)
EP (1) EP2316445A4 (enExample)
JP (2) JP5544660B2 (enExample)
KR (1) KR101274543B1 (enExample)
CN (1) CN102149375B (enExample)
CA (1) CA2727223C (enExample)
WO (1) WO2009151094A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2922552T3 (es) * 2014-11-03 2022-09-16 Nestle Sa Métodos que utilizan la temperatura facial para evaluar el impacto posterior a la ingestión de los ingredientes alimentarios en la oxidación de grasas
US9561206B2 (en) * 2015-01-07 2017-02-07 The United States Of America, As Represented By The Secretary Of The Navy Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome
EP3661600A4 (en) 2017-10-23 2021-08-11 Epitracker, Inc. FATTY ACID ANALOGS AND ITS USE IN THE TREATMENT OF DISEASES RELATED TO METABOLISM SYNDROME
AU2019274431B2 (en) 2018-05-23 2025-03-13 Epitracker, Inc. Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
EP3908374A4 (en) 2019-01-09 2022-12-28 Epitracker, Inc. COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES
JP7404382B2 (ja) 2019-03-04 2023-12-25 エピトラッカー インコーポレイテッド 脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用
JP7500037B2 (ja) * 2019-07-24 2024-06-17 国立大学法人 東京大学 血中尿酸値低下剤及び血中尿酸値低下用食品組成物
WO2023080939A1 (en) 2021-11-03 2023-05-11 Epitracker, Inc. Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2173545C (en) * 1995-04-07 2004-06-29 Kalyana Sundram Increasing the hdl level and the hdl/ldl ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
US5578334A (en) * 1995-04-07 1996-11-26 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum with fat blends
EP1285590A1 (en) * 2001-08-08 2003-02-26 Société des Produits Nestlé S.A. Lipid blends
RU2305547C2 (ru) * 2001-08-23 2007-09-10 Вестгейт Байолоджикал Лимитед Применение апопротеинов сыворотки молока в профилактике или лечении микробной или вирусной инфекции
EP1508335B1 (en) * 2002-05-27 2011-09-28 Morinaga & Co. Ltd. Compositions comprising a cocoa fraction for use in the treatment of periodontitis caused by bacteria belonging to genus porphyromonas, prevotella, fusobacterium or actinobacillus
JP2004075653A (ja) * 2002-06-19 2004-03-11 Nisshin Oillio Ltd 体脂肪分解促進剤および飲食物
WO2004022049A1 (ja) * 2002-09-05 2004-03-18 The Nisshin Oillio Group, Ltd. 痩身剤およびその飲食物
AU2003261928A1 (en) * 2002-09-05 2004-03-29 The Nisshin Oillio Group, Ltd. Agents, foods and drinks controlling lipid metabolism
JP5102435B2 (ja) 2002-10-08 2012-12-19 株式会社リコム キトサン含有多糖、その製造方法及び用途
JP2006096666A (ja) 2002-10-31 2006-04-13 Kaneka Corp 選択的ヒトβ３アドレナリン受容体アゴニスト剤
JP2005015358A (ja) * 2003-06-25 2005-01-20 Pharma Design Inc 摂食障害の治療に供される医薬組成物
US20080146657A1 (en) * 2003-11-04 2008-06-19 Hiroshi Tsuboi Plant-Origin Alpha3-Adrenoceptor Agonist and Use of the Same
JP2005179264A (ja) * 2003-12-19 2005-07-07 Shokubutsu Kogaku Kenkyusho:Kk 体重増加抑制剤
US20060084637A1 (en) * 2004-10-18 2006-04-20 Maria Alemany Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
US20080200707A1 (en) * 2005-01-04 2008-08-21 Mochida-Pharmaceuticals Pharmaceutical Co., Ltd. Lipotoxicity Relieving Agent
CA2593768C (en) * 2005-01-04 2014-02-18 Mochida Pharmaceutical Co., Ltd. Use of .omega.3 unsaturated fatty acids for relieving lipotoxicity
GB0514463D0 (en) * 2005-01-31 2005-08-17 Loders Croklaan Bv Use of pinolenic acid
WO2008000440A1 (en) * 2006-06-27 2008-01-03 Lipid Nutrition B.V. Use of a polyunsaturated fatty acid compound

Similar Documents

Publication Publication Date Title
JP2014080432A5 (enExample)
JP2016518337A5 (enExample)
JP2014221779A5 (enExample)
JP2016135874A5 (enExample)
JP2015527333A5 (enExample)
JP2017536228A5 (enExample)
JP2014218522A5 (enExample)
JP2017531686A5 (enExample)
JP2017513944A5 (enExample)
JP2015510922A5 (enExample)
JP2017014205A5 (enExample)
JP2019518052A5 (enExample)
JP2015113322A5 (enExample)
JP2019516777A5 (enExample)
JP2016150915A5 (ja) ヒトキマーゼ阻害剤および機能性食品、並びにヒトキマーゼの活性を阻害する方法
CN302557966S (zh) 去皮器（追云横）
CN302576353S (zh) 煎烤机(30k08)
CN302532199S (zh) 单连组合式家具（m06）
CN302512964S (zh) 拉链牙（爱心）
CN302456294S (zh) 脱粒机
CN302524330S (zh) 盘（1996013）
CN302523901S (zh) 二连组合式家具（m10）
CN302523486S (zh) 转椅（a288）
CN302557449S (zh) 二连组合式家具（m09）
CN302422062S (zh) 方便面包装碗（红烧排骨）